Literature DB >> 27979420

Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria.

Sheng Tao Yan1, Li Chao Sun1, Hong Bing Jia2, Wen Gao1, Jian Ping Yang1, Guo Qiang Zhang3.   

Abstract

OBJECTIVE: The aim of this study was to evaluate procalcitonin (PCT) diagnostic accuracy in discriminating gram-negative (GN) from gram-positive (GP) bloodstream infections and determining the relationship between PCT levels, infection sites, and pathogen types.
METHODS: Clinical and laboratory data were collected from patients with blood culture (BC)-positive sepsis between January 2014 and December 2015. PCT levels at different infection sites were compared, as was the presence of GN and GP bloodstream infection. A receiver operating characteristic (ROC) curve was generated to assess diagnostic accuracy.
RESULTS: Of the 486 monomicrobial BCs, 254 (52.26%) were positive for GN bacteria (GNB), and 202 (42.18%) for GP bacteria (GPB). Median PCT levels were higher in BCs positive for GN (2.42ng/ml, IQR: 0.38-15.52) than in those positive for GPB (0.49ng/ml, IQR: 0.13-5.89) (P<0.001). In the ROC analysis to differentiate between GNB and GPB, the area under the curve was 0.628 (95% CI: 0.576-0.679). When the cutoffs for PCT were 10.335 and 15.000ng/ml, the specificity of GNB infection was 80.2% and 84.2%, respectively. PCT levels caused by GNB differed between Escherichia coli and Acinetobacter baumanni/Burkholderia cepacia, Klebsiella pneumonia and Acinetobacter baumanni. PCT levels caused by GPB differed between Staphylococcus epidermidis/Staphylococcus aureus and Staphylococcus hominis/Staphylococcus haemolyticus, Enterococcus faecium and Enterococcus faecalis/S.hominis/S. haemolyticus. Among patients with known infection sites, there were statistical differences in PCT levels between abdominal infection and pneumonia/infective endocarditis, urinary tract infection and pneumonia/catheter-related infection/infective endocarditis.
CONCLUSION: PCT can distinguish between GNB and GPB infection, as well as between different bacterial species and infection sites.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial species; Gram-negative bacteria; Gram-positive bacteria; Infection sites; Positive blood culture; Procalcitonin; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 27979420     DOI: 10.1016/j.ajem.2016.12.017

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  22 in total

1.  A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam.

Authors:  Alessandra Iacovelli; Martina Spaziante; Samir Al Moghazi; Alessandra Giordano; Giancarlo Ceccarelli; Mario Venditti
Journal:  Infection       Date:  2018-06-20       Impact factor: 3.553

2.  A risk score for early predicting bloodstream infections in febrile obstetric patients: a pilot study.

Authors:  Yaozong Zhang; Lan Li; Yunsheng Yan; Haifeng Qi; Jiali Qin; Li Ren; Ruoxuan Zhang
Journal:  Arch Gynecol Obstet       Date:  2021-10-03       Impact factor: 2.493

3.  Diagnostic Accuracy of Procalcitonin Compared to C-Reactive Protein and Interleukin 6 in Recognizing Gram-Negative Bloodstream Infection: A Meta-Analytic Study.

Authors:  Liying Lai; Yijie Lai; Hao Wang; Liang Peng; Ning Zhou; Yi Tian; Yongfang Jiang; Guozhong Gong
Journal:  Dis Markers       Date:  2020-01-23       Impact factor: 3.434

4.  Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection.

Authors:  Yinzhi Leng; Caiyun Chen; Yongxiang Zhang; Can Luo; Bo Liu
Journal:  Ann Transl Med       Date:  2019-04

5.  The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics.

Authors:  Iram Yunus; Anum Fasih; Yanzhi Wang
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

6.  Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study.

Authors:  Richard J Durrance; Tofura Ullah; Harsh Patel; Grace Martinez; Kelly Cervellione; Veronica B Zafonte; Khalid Gafoor; Farshad Bagheri
Journal:  Biomark Insights       Date:  2020-05-15

7.  Procalcitonin in bloodstream infections: beyond its role as a marker of clinical algorithm to reduce antimicrobial overuse.

Authors:  Yong Kyun Kim
Journal:  Korean J Intern Med       Date:  2017-12-28       Impact factor: 2.884

8.  The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.

Authors:  Shuren Guo; Xiaohuan Mao; Ming Liang
Journal:  Respir Res       Date:  2018-10-01

9.  Specific dynamic of serum procalcitonin in critically ill patients affected by Gram-negative bacilli septic thrombophlebitis.

Authors:  Martina Spaziante; Giancarlo Ceccarelli; Samir Al Moghazi; Francesco Alessandri; Mario Venditti
Journal:  Crit Care       Date:  2018-07-23       Impact factor: 9.097

10.  The clinical value of IL-3, IL-4, IL-12p70, IL17A, IFN-γ, MIP-1β, NLR, P-selectin, and TNF-α in differentiating bloodstream infections caused by gram-negative, gram-positive bacteria and fungi in hospitalized patients: An Observational Study.

Authors:  Xinjun Li; Xiaozhou Yuan; Chengbin Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.